Therefore, while there are discrepancies in SFRP expression likely arising because of the heterogeneity of DNA methylation in PCa, our results demonstrate a link between elevated SFRP2 expression and cancer progression, particularly in PCa, emphasizing the role of SFRP2 in disease progression. Here, SFRP2 is linked to cancer.